Hong Kong, China vs Israel: Treatment success rate: XDR-TB cases
Hong Kong, China
100
in 2022
Israel
100
in 2022
Hong Kong, China rank
1st
Israel rank
1st
Treatment success rate: XDR-TB cases over time
- Hong Kong, China
- Israel
How they compare
Hong Kong, China currently reports 100 against 100 in Israel, a difference of 0.
The two have swapped places 8 times across 12 shared years of data; in 2008 it was Israel ahead.
Hong Kong, China ranks 1st and Israel ranks 1st of 82 countries.
Across the 3 decades both report, Hong Kong, China averaged higher in 2 and Israel in 1.
Head to head by decade
| Decade | Hong Kong, China | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50 | 100 | 50 | Israel |
| 2010s | 77.12 | 62.5 | 14.62 | Hong Kong, China |
| 2020s | 89 | 60 | 29 | Hong Kong, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Hong Kong, China or Israel?
- Hong Kong, China, at 100 against 100 in Israel as of 2022.
- What is the difference in treatment success rate: xdr-tb cases between Hong Kong, China and Israel?
- 0, with Hong Kong, China ahead.
- How many years of comparable data are there for Hong Kong, China and Israel?
- 12 years are reported by both, from 2008 to 2022.
- How do Hong Kong, China and Israel rank globally for treatment success rate: xdr-tb cases?
- Hong Kong, China ranks 1st and Israel ranks 1st of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.